O S I Systems Inc (OSIS) 68.37 $OSIS Ballard Power

New Post Public Reply Private Reply Replies (0) Message Board

Sep 2, 2016 at 5:17 PM

O S I Systems Inc (OSIS) 68.37 $OSIS

Ballard Power (BLDP) to Expand in Japan via Toyota Deal
Zacks Equity Research - Zacks Investment Research - Fri Aug 19, 9:26AM CDT
Ballard Power Systems Inc. (BLDP) has signed an agreement with a unit of the Toyota Group, to expand its operations in Japan.
BLDP: 2.14 (+0.04), AUO: 3.73 (-0.04), OSIS: 68.37 (+0.82), BWXT: 39.30 (+0.18)

OSIS Crosses Above Average Analyst Target
ETFChannel.com - Thu Aug 18, 7:50AM CDT
In recent trading, shares of OSI Systems, Inc. have crossed above the average analyst 12-month target price of $66.25, changing hands for $68.23/share.
OSIS: 68.37 (+0.82)

Target and Barnes & Noble tumble; Urban Outfitters soars
AP - Wed Aug 17, 3:41PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily on Wednesday:
URBN: 36.10 (+0.32), SPLS: 8.56 (+0.05), TGT: 70.81 (+0.23), LL: 15.91 (+0.31), OSIS: 68.37 (+0.82), BKS: 11.53 (+0.10), CREE: 24.65 (+0.27)

OSI Systems Reports Fourth Quarter and Fiscal Year 2016 Financial Results
BusinessWire - Tue Aug 16, 3:05PM CDT
--GAAP EPS of $0.30
OSIS: 68.37 (+0.82)

Electronic Stocks Earnings Slated Next Week: A, JKHY & More
Zacks Equity Research - Zacks Investment Research - Fri Aug 12, 8:20AM CDT
Five electronics stocks - Agilent Technologies, Inc. (A), Jack Henry & Associates Inc. (JKHY), Keysight Technologies, Inc. (KEYS), Fabrinet (FN) and OSI Systems, Inc. (OSIS), are scheduled to release quarterly numbers next week.
A: 47.00 (+0.01), FN: 40.48 (+1.25), JKHY: 88.94 (+0.74), KEYS: 30.44 (-0.15), OSIS: 68.37 (+0.82)

OSI Systems Announces Fourth Quarter and Fiscal Year End Conference Call
BusinessWire - Tue Aug 09, 4:55PM CDT
OSI Systems, Inc. (Nasdaq: OSIS) today announced that it will hold its quarterly conference call on Tuesday, August 16, 2016 at 1:30pm PT to discuss its results for the fourth quarter and fiscal year ended June 30, 2016.
OSIS: 68.37 (+0.82)

American Science and Engineering, Inc. Reports Results for First Quarter Fiscal Year 2017
GlobeNewswire - Mon Aug 08, 3:06PM CDT
-- Revenues for the first quarter reported at $28.2 million
OSIS: 68.37 (+0.82), ASEI: 37.13 (+0.17)

Maxwell (MXWL) Q2 Loss Wider than Expected, Sales Decline
Zacks Equity Research - Zacks Investment Research - Wed Aug 03, 8:42AM CDT
Maxwell Technologies, Inc. (MXWL) incurred an adjusted loss of 17 cents per share in the second quarter of 2016, wider than both the Zacks Consensus Estimate of a loss of 9 cents and the year-ago loss of 14 cents.
MXWL: 5.19 (+0.10), SRI: 17.70 (+0.03), TTMI: 10.85 (-0.01), OSIS: 68.37 (+0.82)

OSI Systems Has Returned 38.5% Since SmarTrend Recommendation (OSIS)
Comtex SmarTrend(R) - Thu Jun 23, 12:35AM CDT
SmarTrend identified a Downtrend for OSI Systems (NASDAQ:OSIS) on December 10th, 2015 at $90.68. In approximately 7 months, OSI Systems has returned 38.55% as of today's recent price of $55.73.
OSIS: 68.37 (+0.82)

Shareholder Alert: Pomerantz LLP Investigates Claims That the Merger May Not Be in the Best Interest of Investors of American Science & Engineering, Inc. - ASEI
PR Newswire - Wed Jun 22, 10:15AM CDT
Pomerantz LLP is investigating claims on behalf of investors of American Science & Engineering, Inc. ("American Science" or the "Company"

(NASDAQ: ASEI) (ISIN: US02942291077) (CUSIP: 0294229107) concerning the proposed acquisition of American by OSI Systems, Inc.
ASEI: 37.13 (+0.17), OSIS: 68.37 (+0.82)

Ryan & Maniskas, LLP Announces Investigation of American Science & Engineering Inc.
PR Newswire - Wed Jun 22, 9:56AM CDT
Ryan & Maniskas, LLP is investigating potential claims against the board of directors of American Science & Engineering Inc. ("AS&E" or the "Company"

(NASDAQ: ASEI) concerning possible breaches of fiduciary duty and other violations of law related to the Company's efforts to sell the Company to OSI Systems, Inc. in a transaction valued at approximately $269 million.
ASEI: 37.13 (+0.17), OSIS: 68.37 (+0.82)

OSI Systems (OSIS) in Focus: Stock Moves 9.1% Higher
Zacks Equity Research - Zacks Investment Research - Wed Jun 22, 7:05AM CDT
OSI Systems, Inc. (OSIS) was a big mover last session, as the company saw its shares rise more than 9% on the day.
FN: 40.48 (+1.25), OSIS: 68.37 (+0.82)

Asian shares mostly up as investors await more Brexit polls
By TERESA CEROJANO - AP - Tue Jun 21, 10:52PM CDT
MANILA, Philippines (AP) — Asian shares were mostly higher Wednesday, with investors focused on Thursday's vote on Britain's possible withdrawal from the European Union and after relief over U.S. Federal Reserve Chair Janet Yellen's statement that the Fed would remain cautious in raising interest rates.
AGN: 235.96 (-1.80), T: 40.95 (-0.01), OSIS: 68.37 (+0.82), VZ: 52.88 (+0.32), UAL: 51.09 (+0.20)

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of American Science and Engineering, Inc. And Encourages Investors To Contact The Firm For Additional Information
BusinessWire - Tue Jun 21, 1:55PM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of American Science and Engineering, Inc. (NASDAQ: ASEI) ("American Science" or the "Company"

relating to the proposed buyout of American Science by OSI Systems, Inc.
ASEI: 37.13 (+0.17), OSIS: 68.37 (+0.82)

AMERICAN SCIENCE (ASEI) ALERT: Johnson & Weaver, LLP Launches an Investigation into the Fairness of Price and Process in Proposed Sale of American Science and Engineering, Inc.; Are Shareholders Getting a Fair Price?
PR Newswire - Tue Jun 21, 7:13AM CDT
Shareholder rights law firm Johnson & Weaver, LLP has launched an investigation into whether the board members of American Science and Engineering, Inc. NASDAQ: ASEI) breached their fiduciary duties in connection with the proposed sale of the Company to OSI Systems, Inc. (NASDAQ: OSIS).
OSIS: 68.37 (+0.82), ASEI: 37.13 (+0.17)

OSI Systems Enters into Definitive Agreement to Acquire American Science and Engineering
BusinessWire - Tue Jun 21, 6:05AM CDT
--Expected to be accretive to fiscal year 2017 non-GAAP diluted earnings per share excluding one-time transaction expenses and integration costs; at least 10% accretive to fiscal year 2018 GAAP diluted earnings per share.
ASEI: 37.13 (+0.17), OSIS: 68.37 (+0.82)

OSI Systems Has Returned 41.7% Since SmarTrend Recommendation (OSIS)
Comtex SmarTrend(R) - Wed Jun 15, 1:00PM CDT
SmarTrend identified a Downtrend for OSI Systems (NASDAQ:OSIS) on December 10th, 2015 at $90.68. In approximately 6 months, OSI Systems has returned 41.69% as of today's recent price of $52.88.
OSIS: 68.37 (+0.82)

OSI Systems Down 41.4% Since SmarTrend Downtrend Call (OSIS)
Comtex SmarTrend(R) - Wed Jun 08, 12:31AM CDT
SmarTrend identified a Downtrend for OSI Systems (NASDAQ:OSIS) on December 10th, 2015 at $90.68. In approximately 6 months, OSI Systems has returned 41.42% as of today's recent price of $53.12.
OSIS: 68.37 (+0.82)

OSI Systems to Present at the Jefferies 2016 Global Healthcare Conference
BusinessWire - Mon Jun 06, 7:00AM CDT
OSI Systems, Inc. (NASDAQ: OSIS), today announced that it will be presenting at the Jefferies Global Healthcare Conference on Tuesday, June 7, 2016 at 9:30 AM ET.
OSIS: 68.37 (+0.82)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Intelligent Communication Forum Eyes Global Ecosystem Shift

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Gildan's Crisis: Investors Face Losses Amid Lawsuit

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

ASTS Faces Class Action; Investors Beware of Pitfalls

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

LG's ASIL D Certification: A Game Changer in Autos

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

D-Wave's Legal Trouble: Securities Fraud Suit Looms

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

CureGene's Evategrel Aims for Breakthrough in Stroke Care

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

GlycoNex Eyes Japanese Market with Denosumab Biosimilar

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Fibocom Unveils U6G Solutions Advancing Global 5G Tech

Breaking Barriers with U6G-Capable Technology Sneaking into the industry's spotlight at MWC Doha 2026, Fibocom flaunts a robust lineup of next-gen 5G solutions. It's as if they're shuffling every card they’ve got to win over the broadband world. With breakthroughs like the FG390, FG370, and FG670 modules, alongside PCBA-level innovations, Fibocom is not just throwing...

Novo's Semaglutide Shows Promise in MASH Study

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...